224 related articles for article (PubMed ID: 21263242)
21. Microarray study of gene expression in uterine leiomyoma.
Litovkin KV; Ivanova OV; Bauer A; Hoheisel JD; Bubnov VV; Zaporozhan VN
Exp Oncol; 2008 Jun; 30(2):106-11. PubMed ID: 18566572
[TBL] [Abstract][Full Text] [Related]
22. Familial cutaneous and uterine leiomyomas: case report.
Cisło M; Szepietowski F; Wasik JC; Maj J; Hryncewicz-Gwózdz A; Nockowski P
Acta Dermatovenerol Croat; 2003 Dec; 11(4):212-6. PubMed ID: 14670220
[TBL] [Abstract][Full Text] [Related]
23. Carcinosarcoma arising in a uterine leiomyoma: report of a unique neoplasm.
Collins DW; Menon PA; Carr JV; McCluggage WG
Int J Gynecol Pathol; 2011 Nov; 30(6):576-80. PubMed ID: 21979594
[TBL] [Abstract][Full Text] [Related]
24. Cytogenetics of parametrial leiomyoma.
Dahlenfors R; Havel G; Wedell B; Mark J
Anticancer Res; 1997; 17(3C):2121-2. PubMed ID: 9216674
[TBL] [Abstract][Full Text] [Related]
25. A uterine leiomyoma in which a leiomyosarcoma with osteoclast-like giant cells and a metastasis of a ductal breast carcinoma are present.
van Meurs HS; Dieles JJ; Stel HV
Ann Diagn Pathol; 2012 Jan; 16(1):67-70. PubMed ID: 21216642
[TBL] [Abstract][Full Text] [Related]
26. Reduced expression of calponin h1 in leiomyosarcoma of the uterus.
Horiuchi A; Nikaido T; Ito K; Zhai Y; Orii A; Taniguchi S; Toki T; Fujii S
Lab Invest; 1998 Jul; 78(7):839-46. PubMed ID: 9690561
[TBL] [Abstract][Full Text] [Related]
27. [Lipoleiomyoma of the uterus--report of a case].
Sonobe H; Hayashi K; Takahashi K; Ohtsuki Y; Moriki T; Tsukahara Y; Sagara Y
Gan No Rinsho; 1988 Nov; 34(14):2019-22. PubMed ID: 3204666
[TBL] [Abstract][Full Text] [Related]
28. [Uterine lipoma localized in the myometrium. Report of a case, and review of the literature].
Alonso EE; Roma S; Burich S; Fodor M; Nasio C
Ginecol Obstet Mex; 1995 Jan; 63():30-2. PubMed ID: 7896154
[TBL] [Abstract][Full Text] [Related]
29. Pure uterine lipoma.
Imenpour H; Petrogalli F; Anselmi L
Pathologica; 2013 Feb; 105(1):24-7. PubMed ID: 23858948
[TBL] [Abstract][Full Text] [Related]
30. Giant lipoleiomyoma of the uterine corpus.
Akbulut M; Soysal ME; Duzcan SE
Arch Gynecol Obstet; 2008 Sep; 278(3):291-3. PubMed ID: 18283478
[TBL] [Abstract][Full Text] [Related]
31. Identification of a YAC spanning the translocation breakpoints in uterine leiomyomata, pulmonary chondroid hamartoma, and lipoma: physical mapping of the 12q14-q15 breakpoint region in uterine leiomyomata.
Fejzo MS; Yoon SJ; Montgomery KT; Rein MS; Weremowicz S; Krauter KS; Dorman TE; Fletcher JA; Mao JI; Moir DT
Genomics; 1995 Mar; 26(2):265-71. PubMed ID: 7601452
[TBL] [Abstract][Full Text] [Related]
32. Uterine lipoleiomyoma: a histopathological review of 17 cases.
Aung T; Goto M; Nomoto M; Kitajima S; Douchi T; Yoshinaga M; Yonezawa S
Pathol Int; 2004 Oct; 54(10):751-8. PubMed ID: 15482564
[TBL] [Abstract][Full Text] [Related]
33. Lipoleiomyoma of uterus--an uncommon lesion.
Logani KB; Agarwal K; Mukherjee J; Goyal R
J Indian Med Assoc; 1998 Oct; 96(10):321. PubMed ID: 10063306
[No Abstract] [Full Text] [Related]
34. [Case report of lipoleiomyoma of the uterus].
Ohtsuki Y; Mizobuchi T; Sagara S; Takahashi T; Takeda I; Akagi T
Gan No Rinsho; 1983 Jun; 29(7):859-62. PubMed ID: 6876457
[TBL] [Abstract][Full Text] [Related]
35. Leiomyosarcoma of uterus--a case report.
Singh AM; Konjengbam R; Devi SS; Devi NP
J Indian Med Assoc; 2006 Mar; 104(3):142, 144, 147. PubMed ID: 16910338
[TBL] [Abstract][Full Text] [Related]
36. [Lipoma of the uterus: clinical and ethiopathological approach of 7 cases with immunohistochemical study of histogenesis].
El Amine El Hadj O; Bouraoui S; Ben Fadhel CG; Lahmar A; Mzabi-Regaya S
Tunis Med; 2010 Dec; 88(12):916-9. PubMed ID: 21136360
[TBL] [Abstract][Full Text] [Related]
37. Uterine cellular leiomyomata with chromosome 1p deletions represent a distinct entity.
Hodge JC; Pearce KE; Clayton AC; Taran FA; Stewart EA
Am J Obstet Gynecol; 2014 Jun; 210(6):572.e1-7. PubMed ID: 24412114
[TBL] [Abstract][Full Text] [Related]
38. Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway.
Crabtree JS; Jelinsky SA; Harris HA; Choe SE; Cotreau MM; Kimberland ML; Wilson E; Saraf KA; Liu W; McCampbell AS; Dave B; Broaddus RR; Brown EL; Kao W; Skotnicki JS; Abou-Gharbia M; Winneker RC; Walker CL
Cancer Res; 2009 Aug; 69(15):6171-8. PubMed ID: 19622772
[TBL] [Abstract][Full Text] [Related]
39. Family history of uterine fibroids associated with low level of fumarate hydratase in leiomyomata cells.
Shveiky D; Rojansky N; Ben Bassat H; Ben Meir A; Klein B; Shushan A
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):234-5. PubMed ID: 19595497
[No Abstract] [Full Text] [Related]
40. Expression profile of the tumorigenic factors associated with tumor size and sex steroid hormone status in uterine leiomyomata.
Wei JJ; Chiriboga L; Mittal K
Fertil Steril; 2005 Aug; 84(2):474-84. PubMed ID: 16084893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
